Press Release Summary:
Using Indicia for Admission Support, hospitals can rapidly make and document evidence-based decisions about when to admit patients to observation or inpatient care. Program helps hospitals identify diagnoses presenting highest risk of short-stay audit, particularly for Medicare population. Articulating evidence-based rationale in medical record helps to mitigate short-stay denials. Additionally, solution facilitates efficient management of observation stays through to admission or discharge.
Original Press Release:
New Clinical Workflow Solution from MCG Helps Hospitals Rapidly Determine and Document Evidence-based Admission Decisions
Indicia® for Admission Support Informs the Decision to Admit Patients to Inpatient or Observation Care
SEATTLE, -- MCG (part of the Hearst Health network), supplier of evidence-based clinical guidance, recently released Indicia for Admission Support, the latest in its Indicia suite of solutions for providers, designed to help hospitals rapidly make and document evidence-based decisions about when to admit patients to observation or inpatient care.
"Determining the right level of care for certain diagnoses can be quite challenging," says Jon Shreve, President of MCG. "Indicia for Admission Support will help care teams quickly identify the complex medical factors influencing those determinations, enabling them to make confident decisions to admit patients or assign them to observation care."
MCG designed Indicia for Admission Support to help hospitals identify diagnoses presenting the highest risk of a short-stay audit, particularly for the Medicare population. By reviewing complex medical factors that often extend a hospital stay, care teams can determine the need to admit patients that typically require short stays. Articulating that evidence-based rationale in the medical record helps to mitigate short-stay denials.
Additionally, Indicia for Admission Support facilitates the efficient management of observation stays through to admission or discharge. Rapid status determinations optimize the throughput of observation care resources, freeing clinical time and space for other patients in need. The solution reminds care teams to check back on patients in the observation unit as they approach stay limits pertinent to Medicare Part A or Part B billing criteria.
MCG, now part of the Hearst Health network, independently develops and produces evidence-based clinical guidelines and software used by more than 2,200 clients, including 1,300 hospitals and eight of the ten largest U.S. health plans. Updated annually by an experienced team of clinicians, the care guidelines support the care management of a majority of Americans. For more information, visit www.mcg.com.
MCG is part of the Hearst Health network, which also includes FDB (First Databank), Zynx Health and Homecare Homebase. The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person's health journey. Each year in the U.S., care guidance from the Hearst Health network reaches 76% of discharged patients, 133 million insured individuals, 30 million home health visits, 1.88 billion retail pharmacy prescriptions and 3.26 billion prescription claims. Extensions of the Hearst Health network include Hearst Health Ventures and the Hearst Health Innovation Lab. www.hearsthealth.com
Tel +1 206 389 5405